In nearly half of all US metropolitan areas, a single health insurer controls at least 50% of the commercial market, according to the American Medical Association’s 2026 competition study. The report is now in its 25th year and a standard reference for antitrust regulators assessing health insurance market structure.
The study draws on 2025 enrollment data from Decision Resources Group (DRG) across 385 metropolitan statistical areas (MSAs), all 50 states, and the District of Columbia. It applies the Herfindahl-Hirschman Index (HHI), the concentration measure used by the Department of Justice and Federal Trade Commission when reviewing proposed mergers. Authors José R. Guardado and Carol K. Kane are economists in the AMA’s Division of Economic and Health Policy Research.
The numbers have barely shifted over a decade. Under the 2023 DOJ/FTC merger guidelines, 95% of commercial metro markets qualify as highly concentrated, a share that has held between 95% and 97% across all 12 years studied. In 90% of markets, at least one insurer holds a commercial share of 30% or more. In 47% of markets, one insurer holds at least 50%.
Blue Cross Blue Shield (BCBS) insurers held the largest commercial market shares in 84% of metro areas. Among individual carriers, Elevance Health, formerly Anthem, led in 22% of markets, the widest footprint of any single insurer. At the national level, UnitedHealth Group held a 15% commercial share, CVS Health/Aetna 12%, Elevance Health 12%, Cigna 8%, and Health Care Service Corporation/BCBS 8%. Combined, BCBS-branded insurers would account for 42% of the commercial market nationally.
The preferred provider organization (PPO) market is tighter still. This is the product type where most employer-sponsored plans still sit. Ninety-nine percent of metro-area PPO markets are highly concentrated. In 65% of them, one insurer holds at least half of enrollment. That structural reality defines what alternatives realistically exist when a benefits advisor shops a fully insured PPO renewal for a mid-market client.
Premiums are rising in this environment. KFF’s 2026 Employer Health Benefits Survey found that average annual premiums for employer-sponsored family coverage reached $28,303 in 2026, up 5% from 2025. Workers’ average contributions rose faster, up 9% to $7,471, outpacing wage growth of approximately 3.7%. Employees at smaller firms paid more at an average of $9,687 toward family coverage, against $6,840 at firms with 200 or more workers.
The AMA distinguishes concentration from confirmed anticompetitive conduct. What high concentration signals, the report argues, is that conditions exist for insurers to maintain premiums above competitive levels, because alternative carriers have limited reach in most local markets. The report cites academic research linking consolidation to higher premiums. A 2013 case study of the UnitedHealth-Sierra Health Services merger found commercial premiums in Nevada rose after the deal closed.
The same companies dominating commercial insurance are also the nation’s largest pharmacy benefit managers (PBMs), and some extend further into physician employment and provider ownership. UnitedHealth Group, the largest commercial and Medicare Advantage insurer, employs close to 10,000 physicians and affiliates with an estimated 80,000 more. When a carrier controls the network, administers the drug benefit, and employs a portion of local physicians, independent competitors and alternative funding arrangements face structural barriers beyond premium pricing alone.
That dynamic partly explains the growth of self-funded ASO plans, which represent the largest single funding segment in the US employer health market, according to recent industry data. Moving eligible clients off fully insured carrier paper is one of the few levers that changes the structural equation rather than just negotiating inside it. The tradeoffs are no guaranteed renewal, reduced ACA consumer protections, and direct financial exposure in high-claims years, as advisors who have guided employers through the transition are well aware.
Medicare Advantage markets are separately concentrated. Under federal guidelines, 97% of MA metro markets were highly concentrated in 2025, down only slightly from 99% in 2017. The average MA market HHI rose for the first time in the study period in 2025, reversing a gradual improvement since 2017. UnitedHealth Group leads MA nationally with a 30% share, followed by Humana at 17% and CVS/Aetna at 12%.
The 10 states with the least competitive commercial markets in 2025 were Alabama, Kentucky, Hawaii, Louisiana, Michigan, Illinois, Alaska, Indiana, Vermont, and West Virginia. Alabama has held the top position for years. A single insurer, Blue Cross Blue Shield of Alabama, accounts for the overwhelming majority of the state’s commercial enrollment, leaving employers there with almost no meaningful carrier alternative at renewal.
Six states hit 10-year concentration peaks in 2025. These are Connecticut, Illinois, Indiana, Montana, South Dakota, and West Virginia.